CIBC Private Wealth Group LLC reduced its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 646,216 shares of the company’s stock after selling 34,235 shares during the period. CIBC Private Wealth Group LLC’s holdings in Avantor were worth $14,301,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of AVTR. Vanguard Group Inc. boosted its holdings in shares of Avantor by 1.9% in the 4th quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company’s stock valued at $1,347,843,000 after purchasing an additional 1,211,418 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its position in shares of Avantor by 41.4% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company’s stock worth $643,227,000 after buying an additional 8,936,879 shares during the period. State Street Corp boosted its holdings in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after acquiring an additional 8,206,695 shares during the last quarter. Janus Henderson Group PLC grew its position in Avantor by 18.2% during the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after acquiring an additional 2,719,615 shares during the period. Finally, Geode Capital Management LLC increased its stake in Avantor by 7.1% during the third quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock worth $287,791,000 after acquiring an additional 739,667 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Avantor news, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Read Our Latest Research Report on AVTR
Avantor Stock Up 0.3 %
Shares of NYSE:AVTR opened at $16.24 on Tuesday. The firm has a market cap of $11.05 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The company has a fifty day simple moving average of $18.28 and a 200 day simple moving average of $21.28. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 12-month low of $15.37 and a 12-month high of $28.00.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the business posted $0.22 earnings per share. On average, equities research analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- Investing in Travel Stocks Benefits
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- How is Compound Interest Calculated?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.